Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 8/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.44 |
| ▸ | RARA | P10276 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.43 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25623345 | 0.92 | L3MBTL1 (0.51) | RARBFFAR4PLA2G4BL3MBTL1FFAR1 | |
| SCHEMBL25427287 | 0.92 | L3MBTL1 (0.51) | RARBFFAR4PLA2G4BL3MBTL1FFAR1 | |
| SCHEMBL17721288 | 0.92 | L3MBTL1 (0.51) | RARBFFAR4PLA2G4BL3MBTL1FFAR1 | |
| SCHEMBL25623340 | 0.92 | L3MBTL1 (0.51) | RARBFFAR4PLA2G4BL3MBTL1FFAR1 | |
| SCHEMBL25897953 | 0.83 | RARB (0.45) | RARBL3MBTL1RARAKDM4ENPC1 | |
| SCHEMBL25898026 | 0.83 | RARB (0.45) | RARBL3MBTL1RARAKDM4ENPC1 | |
| SCHEMBL21125363 | 0.79 | L3MBTL1 (0.46) | RARBL3MBTL1RARAKDM4ENPC1 | |
| SCHEMBL25493962 | 0.79 | L3MBTL1 (0.46) | RARBL3MBTL1RARAKDM4ENPC1 | |
| SCHEMBL24411666 | 0.79 | USP2 (0.52) | RARBL3MBTL1KDM4ENPC1ALDH1A1 | |
| SCHEMBL21787229 | 0.78 | CDK5 (0.46) | RARBL3MBTL1RARAKDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894091-B2 | Linker units and molecular constructs comprising the same | Immunwork Inc. (TW) | 2021-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894091-B2 | Linker units and molecular constructs comprising the same | CD2BP2, BCR, UACA | RARB 2336/4885FFAR4 4717/4885PLA2G4B 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.